Menquadfi meningococcal (groups A, C, W, Y) conjugate vaccine 0.5ml solution for injection POM X 1
What is Medquadfi?
MenQuadfiTM is indicated for active immunisation of individuals from the age of 12 months and older against invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, W and Y.
What is Menquafi used for?
MenQuadfi is designed to help protect individuals aged 12 months and older against IMD caused by serogroups A, C, W and Y. It is the only MenACWY conjugate vaccine in Europe available in a fully liquid formulation.9,10 This can potentially save time and reduce reconstitution errors.
MenQuadfi uses a tetanus toxoid carrier protein, which is able to impact the T-cell dependent immune system.
In clinical trials, the safety of MenQuadfi was shown to be similar to comparator vaccines.
A MenACWY certificate will be provided on ordering MenQuadfi.
Neisseria meningitidis bacteria (also called meningococci) can be passed from person to person and can cause serious and sometimes life-threatening infections, such as:
• Meningitis – an inflammation of the tissues that surround the brain and spinal cord;
• Septicemia – an infection of the blood
Patient info leaflet link:
pil.12818.pdf
Read our learning hub article on Hajj and Umrah vaccination requirements.
